Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,062
High1,074.2
Low1,034
Prev. Close1,064.8
Avg. Traded Price1,059.95
Volume46,457

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1060.002 days ago
1118.002 days ago
arrow

LOWER/UPPER CIRCUITS

893.00
1339.40
arrow
Zota Health Care Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 62.43%, in the last year to ₹295.04 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteQuarterly Revenue,rose 98.2% YoY to ₹144.67 Cr. Its sector's average revenue growth YoY for the quarter was 12.45%.
noteDebt to Equity Ratio,of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 20.66%
Net profit growth 5Y CAGR : %

About Zota Health Care Limited

Zota Health Care Limited is an Indian pharmaceutical company established in 2000, engaged in drug development, manufacturing, and marketing across pharmaceuticals, nutraceuticals, ayurvedic formulations, and over-the-counter (OTC) products for domestic and international markets. Headquartered in Surat, the company operates through a hybrid model combining its own manufacturing capabilities with a vast retail and distribution footprint. Its flagship retail brand, Davaindia, is a private-sector generic pharmacy chain focusing on affordable alternatives to branded medicines, with a nationwide network of 1,582 operational stores as of March 31, 2025.

 

Zota serves customers in 26 Indian states and 30 countries globally, operating one plant and five offices in India plus an international office. Its portfolio includes over 4,000 products, supplying more than 1,050 distributors across India. Davaindia offers 2,000+ SKUs and reaches over 2.44 crore consumers. As of March 31, 2025, Zota Health Care had five subsidiaries.

Key Milestones of Zota Health Care Limited

  • Incorporation in 2000 and acquisitions of brand portfolios in early 2000s.
  • Establishment of export-oriented formulations unit at Sachin SEZ in 2010 and commencement of exports in 2011.
  • WHO-GMP approval in 2012 and launch of Davaindia in 2017.
  • Listing on NSE main board in 2019 and initiation of COCO store model in 2021.
  • Acquisition of 56% stake in Everyday Herbal Group in 2024.
  • Appointment of Mr. Suniel Shetty as brand ambassador in 2025 and expansion of Davaindia store network.

Zota Health Care Limited Business Segment

Manufactures and markets pharmaceuticals, nutraceuticals, ayurvedic formulations, and OTC products, operating a large retail pharmacy chain and a broad distribution network.

Revenue in FY 2024-25 was predominantly from the Davaindia retail pharmacy segment (64%) and Everyday Herbal Group (4%), with domestic sales accounting for 22% and exports contributing 11%. The company’s presence spans 26 states in India and 30 countries abroad.

Zota Health Care Limited Key Management

  • Ketankumar Chandulal Zota – Non-Executive Chairman
  • Moxesh Ketanbhai Zota – Managing Director
  • Himanshu Muktilal Zota – Whole-time Director
  • Viren Manukant Zota – Whole-time Director
  • Kamlesh Rajanikant Zota – Whole-time Director
  • Laxmi Kant Sharma – Executive Director
  • Dr. Sujit Paul – Group Chief Executive Officer (KMP)
  • Viral Mandviwala – Chief Financial Officer
  • CS Ashvin Variya – Company Secretary & Compliance Officer

Latest Updates on Zota Health Care Limited

  • Davaindia expanded to 1,582 operational stores across 23 states and 2 union territories, including 852 COCO and 730 FOFO outlets.
  • Launched Davaindia B2C online portal and mobile app for home delivery.
  • Acquisition of 56% stake in Everyday Herbal Group enhancing OTC portfolio and backward integration.
  • Strategic tie-up with Indian Oil Corporation Limited to optimize operations and reach.
  • Preferential allotment of shares raising paid-up share capital to Rs 30.33 crore by August 2025; substantial investment in subsidiary Davaindia Health Mart Limited.
  • Board proposed capital raise up to Rs 500 crore in September 2025 for growth, acquisitions, and debt repayment.
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

Develops, manufactures, and markets pharmaceutical, nutraceutical, ayurvedic, and OTC products in domestic and international markets; operates Davaindia pharmacy chain focused on affordable generics.

Operates across 26 Indian states and 30 countries, with 1,582 Davaindia stores in 23 states and 2 union territories as of March 31, 2025.

Davaindia retail (64%), domestic sales (22%), exports (11%), and Everyday Herbal Group (4%).